Philip He
3 appearances in the program
Sessions & presentations
PS41: Overcoming Obstacles in Using Hybrid Controls in Phase 2/3 Clinical Trials as the Basis for Regulatory Approval
Presenting Author
Presentation: Bayesian Hybrid Design in Early Phase Oncology Clinical Trials for Combination Therapy Development
Parallel · Fri, Sep 26 , 1:30 PM
Poster Session I
CoAuthor
Presentation: 10: Bayesian Basket Trial Design in Early Oncology: A Practical Local Power Prior Framework
Posters · Thu, Sep 25 , 5:45 PM
TL10-17 Roundtable Discussions
Co-Presenter
Presentation: TL10: Tipping Point Analyses for Time-to-Event Endpoints in Regulatory Submissions
Roundtable · Thu, Sep 25 , 11:45 AM